Literature DB >> 9493956

Cleavage of poly(ADP-ribose) polymerase: a sensitive parameter to study cell death.

P J Duriez1, G M Shah.   

Abstract

Proteases play a crucial role in apoptosis or programmed cell death. The aim of this review is to highlight the purpose for which these proteases are activated, i.e., to specifically cleave a select subset of cellular proteins at an appropriate time during cell death. Poly(ADP-ribose) polymerase (PARP), a nuclear protein implicated in DNA repair, is one of the earliest proteins targeted for a specific cleavage to the signature 89-kDa fragment during apoptosis. Characterization of the apoptotic cleavage of PARP and other target proteins helped in understanding the role of cysteine aspartic acid specific proteases (caspases) in the apoptotic process. We have recently identified that in some models of cell death, the cleavage pattern for PARP is different from production of the signature 89-kDa fragment. Necrotic death of HL-60 cells and apoptotic death of Jurkat cells mediated by granzyme B and perforin were accompanied by distinct additional fragments, suggesting cleavage of PARP at other sites by caspases or other death proteases. This review summarizes how detection and characterization of PARP cleavage could serve as a sensitive parameter for identification of different types of cell death and as a marker for activation of different death proteases. The putative biological functions for early cleavage of PARP in apoptosis are also discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9493956

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  108 in total

Review 1.  Poly(ADP-ribosylation) and apoptosis.

Authors:  A I Scovassi; G G Poirier
Journal:  Mol Cell Biochem       Date:  1999-09       Impact factor: 3.396

Review 2.  Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease.

Authors:  F J Oliver; J Menissier-de Murcia; G de Murcia
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

3.  Mink cell focus-forming murine leukemia virus infection induces apoptosis of thymic lymphocytes.

Authors:  F K Yoshimura; T Wang; F Yu; H R Kim; J R Turner
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 4.  Apoptosis and the balance of homeostatic and pathologic responses to protozoan infection.

Authors:  L Cristina Gavrilescu; Eric Y Denkers
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

5.  Macrocycles that inhibit the binding between heat shock protein 90 and TPR-containing proteins.

Authors:  Veronica C Ardi; Leslie D Alexander; Victoria A Johnson; Shelli R McAlpine
Journal:  ACS Chem Biol       Date:  2011-10-17       Impact factor: 5.100

6.  The TRAIL receptor agonist drozitumab targets basal B triple-negative breast cancer cells that express vimentin and Axl.

Authors:  Jennifer L Dine; Ciara C O'Sullivan; Donna Voeller; Yoshimi E Greer; Kathryn J Chavez; Catherine M Conway; Sarah Sinclair; Brandon Stone; Laleh Amiri-Kordestani; Anand S Merchant; Stephen M Hewitt; Seth M Steinberg; Sandra M Swain; Stanley Lipkowitz
Journal:  Breast Cancer Res Treat       Date:  2016-01-12       Impact factor: 4.872

7.  Role of docosahexaenoic acid in enhancement of docetaxel action in patient-derived breast cancer xenografts.

Authors:  Marnie Newell; Susan Goruk; Vera Mazurak; Lynne Postovit; Catherine J Field
Journal:  Breast Cancer Res Treat       Date:  2019-06-24       Impact factor: 4.872

8.  The anti-protozoan drug nifurtimox preferentially inhibits clonogenic tumor cells under hypoxic conditions.

Authors:  Quhuan Li; Qun Lin; Hoon Kim; Zhong Yun
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

9.  Dopamine induces cell death, lipid peroxidation and DNA base damage in a catecholaminergic cell line derived from the central nervous system.

Authors:  J M Masserano; I Baker; D Venable; L Gong; S J Zullo; C R Merril; R J Wyatt
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

10.  Antitumor activity of novel fluoro-substituted (-)-epigallocatechin-3-gallate analogs.

Authors:  Huanjie Yang; Dong Kui Sun; Di Chen; Qiuzhi Cindy Cui; Yan Yan Gu; Tao Jiang; Wei Chen; Sheng Biao Wan; Q Ping Dou
Journal:  Cancer Lett       Date:  2009-12-03       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.